A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer

BACKGROUND: We aimed to evaluate the efficacy and safety of nab-paclitaxel in patients with refractory advanced non-small cell lung cancer who failed previous chemotherapy. METHODS: Patients were required to have an Eastern Cooperative Oncology Group performance status of 0–2 and adequate organ func...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Hisashi, Taima, Kageaki, Morimoto, Takeshi, Tanaka, Yoshihito, Itoga, Masamichi, Nakamura, Kunihiko, Hayashi, Akihito, Kumagai, Mika, Yasugahira, Hideo, Mikuniya, Megumi, Okudera, Koichi, Takanashi, Shingo, Tasaka, Sadatomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644257/
https://www.ncbi.nlm.nih.gov/pubmed/29037236
http://dx.doi.org/10.1186/s12885-017-3684-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644257/
https://www.ncbi.nlm.nih.gov/pubmed/29037236
http://dx.doi.org/10.1186/s12885-017-3684-8

Ejemplares similares